BAXEFYN Trademark

Trademark Overview

On Friday, December 16, 2011, a trademark application was filed for BAXEFYN with the United States Patent and Trademark Office. The USPTO has given the BAXEFYN trademark a serial number of 79110059. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, December 16, 2021. This trademark is owned by BIOALLIANCE PHARMA. The BAXEFYN trademark is filed in the Pharmaceutical Products category with the following description:

Bio-adhesive pharmaceutical preparations with slow-release of an anti-inflammatory agent used for treating inflammatory diseases and mucitis
baxefyn

General Information

Serial Number79110059
Word MarkBAXEFYN
Filing DateFriday, December 16, 2011
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, December 16, 2021
Registration Number4252187
Registration DateTuesday, December 4, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 18, 2012

Trademark Statements

Goods and ServicesBio-adhesive pharmaceutical preparations with slow-release of an anti-inflammatory agent used for treating inflammatory diseases and mucitis
Translation of Words in MarkThe wording "BAXEFYN" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, December 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMonopar Therapeutics Inc.
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressUS
Party NameONXEO
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameBIOALLIANCE PHARMA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPARIS F75015
FR
Party NameBIOALLIANCE PHARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPARIS F75015
FR

Trademark Events

Event DateEvent Description
Sunday, July 10, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, July 10, 2022DEATH OF INTERNATIONAL REGISTRATION
Saturday, December 4, 2021COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Wednesday, June 26, 2019NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Wednesday, June 26, 2019REGISTERED-SEC.71 ACCEPTED
Thursday, April 18, 2019CHANGE OF OWNER RECEIVED FROM IB
Monday, April 15, 2019TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, January 15, 2019POST REGISTRATION ACTION MAILED - SEC.71
Wednesday, January 9, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 9, 2018TEAS SECTION 71 RECEIVED
Monday, December 4, 2017COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, June 26, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, October 30, 2014NEW REPRESENTATIVE AT IB RECEIVED
Friday, September 6, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, August 1, 2013FINAL DISPOSITION NOTICE SENT TO IB
Thursday, August 1, 2013FINAL DISPOSITION PROCESSED
Monday, March 4, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 4, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, October 16, 2012NOTIFICATION PROCESSED BY IB
Tuesday, September 18, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 18, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 29, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 29, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 29, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 10, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 10, 2012ASSIGNED TO LIE
Saturday, July 28, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 11, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 10, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 10, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 7, 2012ASSIGNED TO EXAMINER
Friday, April 27, 2012REFUSAL PROCESSED BY IB
Friday, April 6, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 6, 2012REFUSAL PROCESSED BY MPU
Wednesday, April 4, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 3, 2012NON-FINAL ACTION WRITTEN
Tuesday, March 27, 2012APPLICATION FILING RECEIPT MAILED
Sunday, March 25, 2012ASSIGNED TO EXAMINER
Friday, March 23, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 22, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

baxefyn inflammatory agent used diseases mucitis treating anti pharmaceutical preparations slow